Syndax Announces Presentation at Stifel 2020 Virtual Healthcare Conference
WALTHAM, Mass., Nov. 11, 2020 /PRNewswire/ — Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Briggs W. Morrison, M.D., Chief Executive…
Comments Off on Syndax Announces Presentation at Stifel 2020 Virtual Healthcare Conference